{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,1,16]],"date-time":"2023-01-16T12:14:09Z","timestamp":1673871249619},"reference-count":23,"publisher":"LLC Obyedinennaya Redaktsiya","issue":"12","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Ter. arkh."],"published-print":{"date-parts":[[2014]]},"DOI":"10.17116\/terarkh2014861210-14","type":"journal-article","created":{"date-parts":[[2016,4,14]],"date-time":"2016-04-14T17:07:12Z","timestamp":1460653632000},"page":"10","source":"Crossref","is-referenced-by-count":6,"title":["Capabilities of 99mTc-pyrphotech single-photon emission computed tomography in combination with myocardial perfusion scintigraphy in the evaluation of inflammatory changes in the heart of patients with persistent atrial fibrillation"],"prefix":"10.26442","volume":"86","author":[{"given":"S. I.","family":"Sazonova","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Iu. B.","family":"Lishmanov","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R. E.","family":"Batalov","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S. V.","family":"Popov","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Iu. N.","family":"Il'iushenkova","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Iu. V.","family":"Rogovskaia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M. Z.","family":"Idrisov","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"18344","reference":[{"key":"key-10.17116\/terarkh2014861210-14-1","unstructured":"Rekomendatsii VNOK i VNOA \"Diagnostika i lechenie fibrillyatsii predserdii\" 2011."},{"key":"key-10.17116\/terarkh2014861210-14-2","unstructured":"\u0424\u0438\u043b\u0430\u0442\u043e\u0432 \u0410.\u0413., \u0422\u0430\u0440\u0430\u0448\u0432\u0438\u043b\u0438 \u042d.\u0413. Epidemiologiya i sotsial'naya znachimost' fibrillyatsii predserdii. Annaly aritmol 2012; 2: 5-13."},{"key":"key-10.17116\/terarkh2014861210-14-3","unstructured":"\u041c\u0438\u0442\u0440\u043e\u0444\u0430\u043d\u043e\u0432\u0430 \u041b.\u0411., \u041a\u0443\u0434\u0430\u0439\u0431\u0435\u0440\u0433\u0435\u043d\u043e\u0432\u0430 \u0410.\u0413., \u0410\u043d\u0442\u043e\u043d\u043e\u0432\u0430 \u0418.\u0412. Fibrillyatsiya predserdii, amiloidoz, miokardit i virusnaya infektsiya. Arterial'naya gipertenziya 2009; 2: 203-208."},{"key":"key-10.17116\/terarkh2014861210-14-4","unstructured":"\u0421\u0442\u043e\u0440\u043e\u0436\u0430\u043a\u043e\u0432 \u0413.\u0418., \u0413\u0435\u043d\u0434\u043b\u0438\u043d \u0413.\u0415., \u0422\u0440\u043e\u043d\u0438\u043d\u0430 \u041e.\u0410. Miokardity. Serdech nedostat 2009; 1: 46-52."},{"key":"key-10.17116\/terarkh2014861210-14-5","unstructured":"\u0413\u0443\u0440\u0435\u0432\u0438\u0447 \u041c.\u0410. Problema nekoronarogennykh zabolevanii miokarda v klinicheskoi praktike Rus med zhurn 1998; 6: 1523-1531."},{"key":"key-10.17116\/terarkh2014861210-14-6","doi-asserted-by":"crossref","unstructured":"Jang S.Y., Cho Y., Song J.H. et al. Complication rate of transfemoral endomyocardial biopsy with fluoroscopic and two-dimensional echocardiographic guidance: a 10-year experience of 228 consecutive procedures. J Korean Med Sci 2013; 28 (9): 1323-1328.","DOI":"10.3346\/jkms.2013.28.9.1323"},{"key":"key-10.17116\/terarkh2014861210-14-7","unstructured":"Strecker T., R\u00f6sch J., Weyand M., Agaimy A. Endomyocardial biopsy for monitoring heart transplant patients: 11-years-experience at a German heart center. Int J Clin Exp Pathol 2013; 6 (1): 55-65."},{"key":"key-10.17116\/terarkh2014861210-14-8","doi-asserted-by":"crossref","unstructured":"Paul M., Stypmann J., Gerss J. et al. Safety of endomyocardial biopsy in patients with arrhythmogenic right ventricular cardiomyopathy: a study analyzing 161 diagnostic procedures. JACC Cardiovasc Interv 2011; 4 (10): 1142-1148.","DOI":"10.1016\/j.jcin.2011.06.015"},{"key":"key-10.17116\/terarkh2014861210-14-9","doi-asserted-by":"crossref","unstructured":"Sudo\u0142-Szopi\u0144ska I., Cwik\u0142a J.B. Current imaging techniques in rheumatology: MRI, scintigraphy and PET. Pol J Radiol 2013; 78 (3): 48-56.","DOI":"10.12659\/PJR.889138"},{"key":"key-10.17116\/terarkh2014861210-14-10","unstructured":"Lishmanov Yu.B., Sazonova S.I., Chernov V.I. et al. The scintigraphic diagnosis of inflammatory heart disease. Med radiol i radiats bezopasnost' 2004; 2: 59-66."},{"key":"key-10.17116\/terarkh2014861210-14-11","doi-asserted-by":"crossref","unstructured":"Lishmanov Y., Minin S., Efimova I. et al. The possible role of nuclear imaging in assessment of the cardiac resynchronization therapy effectiveness in patients with moderate heart failure. Ann Nucl Med 2013; 27 (4): 378-385.","DOI":"10.1007\/s12149-013-0696-6"},{"key":"key-10.17116\/terarkh2014861210-14-12","unstructured":"\u041b\u0438\u0448\u043c\u0430\u043d\u043e\u0432 \u042e.\u0411., \u041a\u0440\u0438\u0432\u043e\u043d\u043e\u0433\u043e\u0432 \u041d.\u0413., \u0418\u043b\u044c\u044e\u0448\u0435\u043d\u043a\u043e\u0432\u0430 \u042e.\u041d. \u0438 \u0434\u0440. Stsintigraficheskaya otsenka strukturno-funktsional'nykh izmenenii miokarda i al'veolyarno-kapillyarnoi pronitsaemosti legkikh u bol'nykh vnebol'nichnoi pnevmoniei. Sib med zhurn 2011; 1: 106-109."},{"key":"key-10.17116\/terarkh2014861210-14-13","doi-asserted-by":"crossref","unstructured":"Wynne J., Holman L.B., Lesch M. Myocardial Scintigraphy by infarct-avid radiotracers. Principles of cardiovascular nuclear medecine. New York: Grune and Stratton 1978; 230.","DOI":"10.1007\/978-3-642-67510-2_4"},{"key":"key-10.17116\/terarkh2014861210-14-14","doi-asserted-by":"crossref","unstructured":"Fuster V., Ryd\u00e9n L.E., Cannom D.S. et al. ACC\/AHA\/ESC 2006 Guidelines for the Management of Patients with Atrial Fibrillation: a report of the American College of Cardiology\/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 Guidelines for the Management of Patients With Atrial Fibrillation): developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society. Circulation 2006; 114 (7): 257-354.","DOI":"10.1161\/CIRCULATIONAHA.106.177292"},{"key":"key-10.17116\/terarkh2014861210-14-15","unstructured":"\u041a\u0440\u0438\u0432\u043e\u043d\u043e\u0433\u043e\u0432 \u041d.\u0413., \u041f\u0438\u0441\u0430\u0440\u0435\u0432\u0430 \u041d.\u0410., \u041b\u0438\u0448\u043c\u0430\u043d\u043e\u0432 \u042e.\u0411. Stsintigrafiya miokarda v diagnostike IBS. Kardiologiya 1987; 27: 113-115."},{"key":"key-10.17116\/terarkh2014861210-14-16","unstructured":"\u0411\u044b\u043a\u043e\u0432 \u0412.\u041b. Tsitologiya i obshchaya gistologiya. Sankt-Peterburg: SOTIS 2002."},{"key":"key-10.17116\/terarkh2014861210-14-17","unstructured":"Aretz H.T., Billingham M.E., Edwards W.D. et al. Myocarditis: a histopathologic definition and classification. Am J Cardiovasc Pathol 1987; 1: 3-14."},{"key":"key-10.17116\/terarkh2014861210-14-18","doi-asserted-by":"crossref","unstructured":"Basso C., Calabrese F., Angelini A. et al. Classification and histological, immunohistochemical and molecular diagnosis of inflammatory myocardial disease. Heart Fail Rev 2013; 18: 673-681.","DOI":"10.1007\/s10741-012-9355-6"},{"key":"key-10.17116\/terarkh2014861210-14-19","unstructured":"\u041c\u0438\u0442\u0440\u043e\u0444\u0430\u043d\u043e\u0432\u0430 \u041b.\u0415., \u041a\u0430\u0440\u0435\u0432 \u0412.\u0415. Miokardity (standarty morfologicheskoi diagnostiki pri autopsii i endomiokardial'noi biopsii). Po red. prof. G.B. Koval'skogo. Biblioteka patologoanatoma 2010; 115: 52."},{"key":"key-10.17116\/terarkh2014861210-14-20","doi-asserted-by":"crossref","unstructured":"Richardson P., McKenna W., Bristow M. et al. Report of the 1995 World Health Organization\/International Society and Federation of Cardiology Task Force on the definition and classification of cardiomyopathies. Circulation 1996; 93: 841-842.","DOI":"10.1161\/01.CIR.93.5.841"},{"key":"key-10.17116\/terarkh2014861210-14-21","doi-asserted-by":"crossref","unstructured":"Aviles R.J., Martin D.O., Apperson-Hansen C. et al. Inflammation as a risk factor for atrial fibrillation. Circulation 2003; 108: 3006-3010.","DOI":"10.1161\/01.CIR.0000103131.70301.4F"},{"key":"key-10.17116\/terarkh2014861210-14-22","doi-asserted-by":"crossref","unstructured":"Asselbergs F.W., Diercks G.F., van den Berg M.P. et al. C-reactive protein and microalbuminuria are associated with atrial fibrillation. JACC 2003; 41: 99-100.","DOI":"10.1016\/S0735-1097(03)81043-4"},{"key":"key-10.17116\/terarkh2014861210-14-23","doi-asserted-by":"crossref","unstructured":"Dernellis J., Panaretou M. Relationship between C-reactive protein concentrations during glucocorticoid therapy and recurrent atrial fibrillation. Eur Heart J 2004; 25: 1100-1107.","DOI":"10.1016\/j.ehj.2004.04.025"}],"container-title":["Terapevticheskii arkhiv"],"original-title":[],"language":"en","deposited":{"date-parts":[[2020,6,28]],"date-time":"2020-06-28T21:23:14Z","timestamp":1593379394000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.mediasphera.ru\/issues\/terapevticheskij-arkhiv\/2014\/12\/downloads\/ru\/030040-36602014122"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014]]},"references-count":23,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2014]]}},"alternative-id":["terarkh2014861210-14"],"URL":"https:\/\/doi.org\/10.17116\/terarkh2014861210-14","relation":{},"ISSN":["0040-3660"],"issn-type":[{"value":"0040-3660","type":"print"}],"subject":[],"published":{"date-parts":[[2014]]}}}